SCHEMBL30906568

CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	BACE1	P56817	6/20	0.54

▸	VIPR1	P32241	3/20	0.54

▸	BACE2	Q9Y5Z0	2/20	0.52

▸	VIPR2	P41587	4/20	0.51

▸	OPRD1	P41143	1/20	0.49

▸	KISS1R	Q969F8	2/20	0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30906565	0.95	BACE1 (0.52)	BACE1VIPR1BACE2VIPR2OPRD1
SCHEMBL30906355	0.90	BACE1 (0.52)	BACE1VIPR1BACE2VIPR2OPRD1
SCHEMBL30432280	0.88	VIPR1 (0.65)	BACE1VIPR1BACE2VIPR2
SCHEMBL29867734	0.88	VIPR1 (0.58)	BACE1VIPR1BACE2VIPR2KISS1R
SCHEMBL31690551	0.87	KISS1R (0.56)	BACE1VIPR1BACE2VIPR2KISS1R
SCHEMBL31690550	0.87	KISS1R (0.56)	BACE1VIPR1BACE2VIPR2KISS1R
SCHEMBL29678306	0.87	KISS1R (0.56)	BACE1VIPR1BACE2VIPR2KISS1R
SCHEMBL30512653	0.86	VIPR1 (0.60)	BACE1VIPR1BACE2VIPR2
SCHEMBL31622476	0.86	VIPR1 (0.55)	BACE1VIPR1BACE2VIPR2KISS1R
SCHEMBL30752379	0.86	VIPR1 (0.55)	BACE1VIPR1BACE2VIPR2KISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed